
New Ray Medicine International Holding Ltd.
6108.HKHKSEHealthcareMedical - Pharmaceuticals
最新数据
HK$0.225
+HK$0.016 · +7.66%
6108.HK公司概览
盘中时间采用HKT。市场数据可能有所延迟。
公司概况
公司网站New Ray Medicine International Holding Ltd. is an investment company, which engages in the distribution and trading of pharmaceutical products. It operates through the following business segments: Injection Drugs; Capsule and Granule Drugs; Tablet Drugs; Marketing and Promotion Services; and Others. The Injection Drugs segment includes the trading of injection drugs. The Capsule and Granule Drugs segment relates to the selling of capsule and granule drugs. The Tablet Drugs segment comprises tablet drugs. The Marketing and Promotion Services segment focuses in the marketing and promotion of services of drugs. The Others segment trades miscellaneous types of goods and drugs, other than injection drugs, capsule and granule drugs, and tablet drugs. The company was founded on August 9, 2012 and is headquartered in Hangzhou, China.
- 行业
- Medical - Pharmaceuticals
- 部门
- Healthcare
- 总部
- CN
- 首席执行官
- Qiuqin Wang
- 上市以来
- 2013年10月28日
- 雇员
- 31
市场位置
52周区间
当前HK$0.225,
- 开盘价
- HK$0.225
- 前收盘价
- HK$0.209
- 成交量
- 7.2万
- 0.79× 平均值
- 平均成交量
- 9.13万
- 日均成交量
- 市值
- 4513.88万 HKD
- 贝塔
- -3.94
- 市场参考 1
- 50天平均值
- HK$0.2061
- 高于平均水平+9.15%
- 200天平均值
- HK$0.2284
- 低于平均水平-1.49%
6108.HK同业公司
继续GoAI的研究
在 GoAI 中研究6108.HKresearch.disclaimer





